Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

Hepatoblastoma is a rare primary liver cancer with an age-adjusted incidence of 0.13 patients per 100,000 population. Hepatoblastoma can be categorized as standard-risk or high-risk disease according to the serum alpha-fetoprotein level in addition to the results of the revised Pretreatment Extent…

https://ift.tt/2KAVcjO